Original Article
Clinical, Patient-Reported, and Ultrasound Outcomes from an Open-Label, 12-week Observational Study of Certolizumab Pegol in Spanish Patients with Rheumatoid Arthritis with or without Prior Anti-TNF Exposure
Estudio observacional con certolizumab pegol de 12 semanas de duración en pacientes con artritis reumatoide con y sin exposición previa a anti-TNF: resultados ecográficos, clínicos y reportados por los pacientes
Francisco J. Blancoa,
, Esteban Rubio-Romerob, Raimon Sanmartíc, César Díaz-Tornéd, Pablo Talaverae, Jochen Dunkelf, Esperanza Naredog, on behalf of the SONAR Study Team
a INIBIC-Complejo Hospitalario Universitario A Coruña, A Coruña, Spain
b Hospital Universitario Virgen del Rocio, Sevilla, Spain
c Hospital Clínic de Barcelona, Barcelona, Spain
d Hospital de la Santa Cruz y San Pablo, Barcelona, Spain
e UCB Pharma, Madrid, Spain
f UCB Pharma, Monheim, Germany
g Department of Rheumatology and Joint and Bone Research Unit, Hospital Fundación Jiménez Díaz, Madrid, Spain
Read
8741
Timeswas read the article
2856
Total PDF
5885
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 8 | 0 | 35 | 35 |
| 2025 7 | 0 | 48 | 48 |
| 2025 6 | 4 | 30 | 34 |
| 2025 5 | 99 | 53 | 152 |
| 2025 4 | 75 | 41 | 116 |
| 2025 3 | 91 | 39 | 130 |
| 2025 2 | 82 | 29 | 111 |
| 2025 1 | 67 | 32 | 99 |
| 2024 12 | 48 | 34 | 82 |
| 2024 11 | 65 | 47 | 112 |
| 2024 10 | 55 | 21 | 76 |
| 2024 9 | 49 | 15 | 64 |
| 2024 8 | 59 | 33 | 92 |
| 2024 7 | 53 | 29 | 82 |
| 2024 6 | 69 | 35 | 104 |
| 2024 5 | 55 | 27 | 82 |
| 2024 4 | 60 | 27 | 87 |
| 2024 3 | 67 | 35 | 102 |
| 2024 2 | 52 | 34 | 86 |
| 2024 1 | 60 | 26 | 86 |
| 2023 12 | 73 | 22 | 95 |
| 2023 11 | 74 | 45 | 119 |
| 2023 10 | 50 | 36 | 86 |
| 2023 9 | 245 | 38 | 283 |
| 2023 8 | 43 | 18 | 61 |
| 2023 7 | 41 | 22 | 63 |
| 2023 6 | 40 | 28 | 68 |
| 2023 5 | 44 | 24 | 68 |
| 2023 4 | 34 | 14 | 48 |
| 2023 3 | 70 | 37 | 107 |
| 2023 2 | 50 | 43 | 93 |
| 2023 1 | 43 | 34 | 77 |
| 2022 12 | 99 | 44 | 143 |
| 2022 11 | 54 | 34 | 88 |
| 2022 10 | 101 | 40 | 141 |
| 2022 9 | 50 | 36 | 86 |
| 2022 8 | 49 | 41 | 90 |
| 2022 7 | 57 | 68 | 125 |
| 2022 6 | 66 | 38 | 104 |
| 2022 5 | 70 | 36 | 106 |
| 2022 4 | 119 | 51 | 170 |
| 2022 3 | 60 | 49 | 109 |
| 2022 2 | 44 | 35 | 79 |
| 2022 1 | 55 | 40 | 95 |
| 2021 12 | 94 | 53 | 147 |
| 2021 11 | 110 | 47 | 157 |
| 2021 10 | 70 | 53 | 123 |
| 2021 9 | 48 | 43 | 91 |
| 2021 8 | 50 | 42 | 92 |
| 2021 7 | 33 | 42 | 75 |
| 2021 6 | 52 | 37 | 89 |
| 2021 5 | 79 | 44 | 123 |
| 2021 4 | 183 | 92 | 275 |
| 2021 3 | 73 | 35 | 108 |
| 2021 2 | 45 | 27 | 72 |
| 2021 1 | 67 | 25 | 92 |
| 2020 12 | 89 | 31 | 120 |
| 2020 11 | 78 | 33 | 111 |
| 2020 10 | 73 | 32 | 105 |
| 2020 9 | 297 | 44 | 341 |
| 2020 8 | 150 | 39 | 189 |
| 2020 7 | 59 | 23 | 82 |
| 2020 6 | 103 | 13 | 116 |
| 2020 5 | 109 | 14 | 123 |
| 2020 4 | 134 | 38 | 172 |
| 2020 3 | 48 | 22 | 70 |
| 2020 2 | 58 | 24 | 82 |
| 2020 1 | 71 | 17 | 88 |
| 2019 12 | 128 | 45 | 173 |
| 2019 11 | 67 | 18 | 85 |
| 2019 10 | 58 | 15 | 73 |
| 2019 9 | 157 | 29 | 186 |
| 2019 8 | 114 | 8 | 122 |
| 2019 7 | 60 | 20 | 80 |
| 2019 6 | 55 | 23 | 78 |
| 2019 5 | 55 | 44 | 99 |
| 2019 4 | 54 | 51 | 105 |
| 2019 3 | 65 | 27 | 92 |
| 2019 2 | 27 | 10 | 37 |
| 2019 1 | 62 | 20 | 82 |
| 2018 12 | 69 | 60 | 129 |
| 2018 11 | 0 | 31 | 31 |
| 2018 10 | 0 | 42 | 42 |
Show all
